Retrospective analysis of a population meeting criteria for the ACCORD lipid trial supported adjunct fenofibrate in patients with reduced low-density lipoprotein cholesterol and elevated triglycerides.
Sherwanna Clarke, PharmD
Advertisement
Articles by Sherwanna Clarke, PharmD
Advertisement
Latest Updated Articles
- Statin-Fenofibrate Combination Therapy in an ACCORD Population: A Retrospective Analysis
Published: October 17th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, HHS Move to Accelerate Biosimilar Approvals
2
Accelerated Approval of Cancer Drugs: Benefit or Burden?
3
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
4
Pharmacists Lead the Way in Evolving CAR T-Cell and Bispecific Antibody Therapy Management
5
